Financhill
Back

Amgen 10K Form

Sell
39

AMGN
Amgen

Last Price:
268.95
Seasonality Move:
4.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-02-14 10K AMGN/Amgen Annual
2023-10-31 10Q AMGN/Amgen Quarterly
2023-08-04 10Q AMGN/Amgen Quarterly
2023-04-28 10Q AMGN/Amgen Quarterly
2023-02-09 10K AMGN/Amgen Annual
2022-11-04 10Q AMGN/Amgen Quarterly

Receive AMGN News And Ratings

See the #1 stock for the next 7 days that we like better than AMGN

AMGN Financial Statistics

Sales & Book Value

Annual Sales: $28.19B
Cash Flow: $289M
Price / Cash Flow: 19.65
Annual Sales: $11.64
Price / Book: 23.13

Profitability

EPS (TTM): 12.49000
Net Income (TTM): $6.72B
Gross Margin: $19.74B
Return on Equity: 113.17%
Return on Assets: 7.78%

Amgen Earnings Forecast

Key Amgen Financial Ratios

  • The Gross Profit Margin over the past 40 years for AMGN is 70.02%.
  • The Selling, General & Administrative Expenses for AMGN have been equal to 21.92% of Gross Profit Margin.
  • The Research & Development expenses have been 16.97% of Revenue.
  • The Interest Expense is 42.80% of Operating Income.
  • The Net Earning history of AMGN is 23.83% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 26 years.

Amgen Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: AMGN
CUSIP: 031162
Website: amgen.com

Debt

Debt-to-Equity Ratio: 10.37
Current Ratio: 1.65
Quick Ratio: 1.03

Price-to-Earnings

Trailing P/E Ratio: 21.53
Forward P/E Ratio: 12.71

AMGN Technical Analysis vs Fundamental Analysis

Sell
39
Amgen (AMGN) is a Sell

Is Amgen a Buy or a Sell?

  • Amgen stock is rated a Sell
    The current Amgen [AMGN] share price is $268.94. The Score for AMGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.